Preparation method of clavulanic acid tert-butylamine salt

A technology of tert-butylamine salt and clavulanic acid, which is applied in the field of preparation of tert-butylamine clavulanic acid, can solve problems such as affecting quality, increasing impurities, and degrading clavulanic acid, so as to improve yield and quality, improve product quality, reduce The effect of impurity content

Active Publication Date: 2018-11-16
SHANXI WEIQIDA PHARMA IND
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] There are certain problems in the above-mentioned preparation process, such as the high power cost of the decompression evaporation concentration process of the clavulanic acid extract, the high local temperature of the evaporator will easily lead to the degradation of the clavulanic acid, and the impurity E will increase significantly and affect the quality of the final product; and Concentrating the clavulanic acid extract by using organic solvent-resistant rolling membrane nanofiltration can avoid various defects of vacuum evaporation and concentration, but due to the high price of organic solvent-resistant rolling membranes, there are not many manufacturers that can produce such membranes. The cycle is short, so the preparation cost of clavulanic acid tert-butylamine salt has not been significantly reduced

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Take 3L clavulanic acid aqueous solution (concentration 18.7mg / mL, pH 5.09), control the temperature at 5°C, adjust the pH to 1.45 with 25% sulfuric acid, add 15L ethyl acetate, mix well, and collect after standing and separating Light phase 14.70L (clavulanic acid concentration 3.7mg / mL). Then, 172mL of ethyl tert-butylamine acetate solution of 20% (v / v) was added dropwise at a uniform speed in the clavulanic acid extract within 15min, and obvious white turbidity would be produced in the process of tert-butylamine flowing but dissolved immediately; in tert-butylamine After the addition of the ethyl acetate solution, let stand for 10 minutes to separate the layers, collect and obtain 164 mL of the heavy phase; then add 72 mL of purified water to the light phase of the ethyl acetate phase, stir and wash with water, then stand for 10 minutes to separate the layers, collect and obtain 54 mL of the heavy phase, combine 218 mL of the heavy phase was obtained.

[0034] At 5°C,...

Embodiment 2

[0036] Take 3L clavulanic acid aqueous solution (concentration 19.1mg / mL, pH 5.14), control the temperature at 5°C, adjust the pH to 1.49 with 25% sulfuric acid, add 15L ethyl acetate, mix well, and collect after standing and separating Light phase 14.67L (clavulanic acid concentration 3.8mg / mL).

[0037] Then, 169mL of ethyl tert-butylamine acetate solution of 20% (v / v) was added dropwise at a uniform speed in the clavulanic acid extract within 15min, and obvious white turbidity would be produced in the process of tert-butylamine flowing but dissolved immediately; in tert-butylamine After the addition of the ethyl acetate solution, let stand for 10 minutes to separate the layers, collect and obtain 160 mL of the heavy phase; then add 73 mL of purified water to the light phase of the ethyl acetate phase, stir and wash with water and let stand for 10 minutes to separate the layers, collect and obtain 55 mL of the heavy phase, combine 215 mL of the heavy phase was obtained.

[...

Embodiment 3

[0040] Take 3L clavulanic acid aqueous solution (concentration 18.4mg / mL, pH 5.11), control the temperature at 5°C, adjust the pH to 1.46 with 25% sulfuric acid, add 15L ethyl acetate, mix well, and collect after standing and separating Light phase 14.72L (clavulanic acid concentration 3.7mg / mL).

[0041] Then, 165mL of ethyl tert-butylamine acetate solution of 20% (v / v) was added dropwise at a uniform speed in the clavulanic acid extract within 15min, and obvious white turbidity would be produced in the process of tert-butylamine flowing but dissolved immediately; in tert-butylamine After the addition of the ethyl acetate solution, let stand for 10 minutes to separate layers, collect and obtain 158 mL of the heavy phase; then add 72 mL of purified water to the light phase of ethyl acetate, stir and wash with water, then stand for 10 minutes to separate the layers, collect and obtain 54 mL of the heavy phase, combine 212 mL of the heavy phase was obtained.

[0042] At 5°C, mi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a preparation method of a clavulanic acid tert-butylamine salt. The preparation method comprises the steps: acidifying a water solution of clavulanic acid, and then, extracting clavulanic acid from the water solution of clavulanic acid by using an organic solvent unmixed with water to obtain a clavulanic acid extracting solution; then, carrying out a mixed reaction on theclavulanic acid extracting solution and tert-butylamine serving as an organic amine donor to form a salt, carrying out standing for layering, and collecting a heavy phase to obtain a clavulanic acid tert-butylamine salt solution with high concentration; and finally, adding a cosolvent into the clavulanic acid tert-butylamine salt solution, and carrying out anti-solvent crystallization, filtration,washing and drying to obtain the clavulanic acid tert-butylamine salt. The preparation method of the clavulanic acid tert-butylamine salt disclosed by the invention is simple and convenient to operate, low in energy consumption and capable of reducing the preparation cost, and the quality of a product is high.

Description

technical field [0001] The invention belongs to the technical field of pharmacy, and more specifically relates to a preparation method of clavulanic acid tert-butylamine salt. Background technique [0002] Potassium clavulanate is a β-lactamase inhibitor widely used clinically, and tert-butylamine clavulanate has a crucial influence on the quality of the final synthetic potassium clavulanate product. At present, its preparation method generally includes: using Streptomyces clavulanic acid fermentation to prepare clavulanic acid fermentation liquid, and then using plate frame, ceramic membrane, ultrafiltration membrane and other methods to remove mycelium, most of the protein and pigment impurities in the fermentation liquid, and then Obtain clavulanic acid aqueous solution after nanofiltration membrane or reverse osmosis membrane concentration; Secondly, use under acidic conditions and water-immiscible solvent to extract clavulanic acid from clavulanic acid aqueous solution,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D503/18C07D503/02
CPCC07D503/02C07D503/18
Inventor 白延峰刘君臣刁夏冯涛李树有
Owner SHANXI WEIQIDA PHARMA IND
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap